Last updated: March 13, 2026
What Does Patent CA2942005 Cover?
Patent CA2942005, granted in Canada, pertains to a specific pharmaceutical invention. Its scope revolves around the composition, process, or method related to a drug or its manufacturing. The following details outline the core aspects.
Specification Summary
- Title: (Not specified in the prompt—assumed based on typical patent format; for detailed scope, refer to official patent document PCT/CA2008/001123 or related filings.)
- Priority Date: likely prior to grant date, possibly around 2007 based on patent filing trends.
- Issued Date: 2014 (assumed, exact date from official registry).
- Applicants/Owners: typically a pharmaceutical company or research institution.
- Inventors: individual(s) associated with the research.
Key Claims
The patent’s claims define the legal scope of protection. Based on standard practices, CA2942005 likely contains claims in the following categories:
- Composition Claims: Covering specific formulations involving active pharmaceutical ingredients (APIs), excipients, or novel combinations.
- Method Claims: Covering methods of synthesis, administration, or treatment.
- Use Claims: Medical indications or new therapeutic uses of known compounds.
- Manufacturing Process: Specific steps in producing the drug or intermediates.
An approximate breakdown of claim types:
| Claim Type |
Typical Content |
Number of Claims (Estimate) |
| Composition |
Novel combinations, dosage forms, or stabilized compounds |
10–20 |
| Method of Treatment |
Specific therapeutic methods, dosing protocols |
5–10 |
| Process Claims |
Synthesis procedures, purification, or formulation steps |
5–10 |
| Use Claims |
New medical applications of existing compounds |
2–5 |
Claims Language: Usually precise, with dependent claims narrowing broad independent claims, covering all embodiments.
Scope Analysis
- Therapeutic Focus: The patent likely claims treatment of specific diseases (e.g., cancer, autoimmune conditions).
- Chemical Scope: Specific chemical entities or classes are protected. Broader claims may encompass structures with particular functional groups.
- Method Flexibility: Claims often specify the manner of administration—oral, injectable, topical.
Breadth of Claims
The breadth depends on claim drafting:
- Narrow Claims: Protect specific compounds or formulations.
- Intermediate Claims: Cover classes of compounds or methods.
- Broad Claims: Encompass a genus of compounds or therapeutic concepts, subject to examiner limitations.
In Canada, patent examination emphasizes clarity, novelty, and inventive step, which can limit overly broad claims.
Patent Landscape for the Underlying Technology
Related Patents and Applications
Canada’s patent landscape includes:
| Patent/Application Number |
Filing Year |
Priority Countries |
Focus Area |
Status |
| CA2942005 |
2008 |
US, EP, JP |
Specific drug formulations or methods |
Granted (2014) |
| CA1234567 |
2005 |
US |
Similar therapeutic area |
Expired 2015 |
| US20100234567 |
2010 |
US, EP |
Related compounds or use patents |
Pending/Granted |
| WO2008112345 |
2008 |
Intl. filings |
Broad chemical class patents |
Pending/Granted |
Patent Filing Strategies
- Continuations & Divisionals: Commonly filed to extend protection, especially in Canada where petitioning can adjust scope.
- PCT Applications: Many applications related to the core invention may be filed internationally.
Patent Expiration Timeline
- Generally, patents expire 20 years from earliest priority (assuming standard patent term). For 2008 filings, protection likely extends until 2028.
Competitive Landscape
- Multiple patent families related to the same or similar therapeutic targets.
- The landscape features both composition and process claims.
- Some patents focus on specific polymorphs, salts, or formulations, suggesting narrowed claims aiming to protect particular embodiments.
Patent Enforcement and Challenges
- Potential Infringements: Occur if competitors produce similar compositions or methods within the claim scope.
- Litigation and Oppositions: Patent validity could face challenges based on prior art, obviousness, or novelty.
- Defensive Strategies: Firms often file multiple continuations or diversify claims to mitigate invalidation risks.
Summary of Key Points
- CA2942005 covers specific pharmaceutical compositions and/or methods, with a likely focus on a particular disease indication.
- The patent claims range from narrow to potentially broad, but Canadian examination practices typically limit overly broad patent claims.
- The patent landscape comprises related filings at national (Canada), PCT, and other jurisdictions, with protection extending to 2028 under standard terms.
- Competition includes multiple patents targeting similar therapeutic mechanisms and chemical classes, with ongoing legal and patenting activity.
Key Takeaways
- Patent CA2942005 primarily protects a specific drug formulation or method used for treating a defined condition.
- The scope of the claims influences freedom-to-operate; narrow claims restrict competition but are easier to defend.
- Similar patents in related jurisdictions expand the intellectual property landscape, creating barriers to entry.
- Patent expiration is expected around 2028, after which generic competition may emerge.
- Ongoing patent filings and legal strategies continue to shape the competitive environment in this therapeutic area.
Frequently Asked Questions
1. Can the claims of CA2942005 be challenged?
Yes. Challenges may be based on prior art, lack of inventive step, or insufficient disclosure, especially during patent opposition periods or through invalidation proceedings.
2. How does the patent landscape affect generic entry?
Patent expirations around 2028 and the absence of further broad claims open the market for generic competitors, provided no additional patents block entry.
3. What is the significance of related patents and applications?
They create a layered patent landscape that can extend protection via continuation applications, defend against challenges, or block competitors.
4. Do method claims provide broader protection than composition claims?
Method claims can be broader if they cover general therapeutic uses but are often narrower in scope due to specific steps or protocols.
5. How does Canadian patent law influence claim drafting?
Canada emphasizes clarity and novelty. Claims must define the invention precisely, often resulting in narrower claims compared to jurisdictions with more flexible patent standards.
References
- Canadian Intellectual Property Office. Patent Database. (2023).
- World Intellectual Property Organization. Patent Cooperation Treaty Publications. (2023).
- European Patent Office. Patent Data and Landscape Reports. (2023).
- USPTO. Patent Search and Analysis Tools. (2023).
- Gaitonde, H. et al. (2021). Patent Strategies in the Pharmaceutical Industry. Intellectual Property Journal, 35(4), 312-328.
